Showing posts with label peptides. Show all posts
Showing posts with label peptides. Show all posts

Wednesday, August 13, 2008

Scientists Overcome Nanotechnology Hurdle

ScienceDaily (Aug. 13, 2008) — When you make a new material on a nanoscale how can you see what you have made? A team lead by a Biotechnology and Biological Sciences research Council (BBSRC) fellow has made a significant step toward overcoming this major challenge faced by nanotechnology scientists.

With new research published August 13 in ChemBioChem, the team from the University of Liverpool, The School of Pharmacy (University of London) and the University of Leeds, show that they have developed a technique to examine tiny protein molecules called peptides on the surface of a gold nanoparticle. This is the first time scientists have been able to build a detailed picture of self-assembled peptides on a nanoparticle and it offers the promise of new ways to design and manufacture novel materials on the tiniest scale - one of the key aims of nanoscience.

Engineering new materials through assembly of complex, but tiny, components is difficult for scientists. However, nature has become adept at engineering nanoscale building blocks, e.g. proteins and RNA. These are able to form dynamic and efficient nanomachines such as the cell's protein assembly machine (the ribosome) and minute motors used for swimming by bacteria.

The BBSRC-funded team, led by Dr Raphaël Lévy, has borrowed from nature, developing a way of constructing complex nanoscale building blocks through initiating self-assembly of peptides on the surface of a metal nanoparticle. Whilst this approach can provide a massive number and diversity of new materials relatively easily, the challenge is to be able to examine the structure of the material.

Using a chemistry-based approach and computer modelling, Dr Lévy has been able to measure the distance between the peptides where they sit assembled on the gold nanoparticle. The technique exploits the ability to distinguish between two types of connection or 'cross-link' - one that joins different parts of the same molecule (intramolecular), and another that joins together two separate molecules (intermolecular).

As two peptides get closer together there is a transition between the two different types of connection. Computer simulations allow the scientists to measure the distance at which this transition occurs, and therefore to apply it as a sort of molecular ruler. Information obtained through this combination of chemistry and computer molecular dynamics shows that the interactions between peptides leads to a nanoparticle that is relatively organized, but not uniform. This is the first time it has been possible to measure distances between peptides on a nanoparticle and the first time computer simulations have been used to model a single layer of self-assembled peptides.

Dr Lévy said: "As nanotechnology scientists we face a challenge similar to the one faced by structural biologists half a century ago: determining the structure with atomic scale precision of a whole range of nanoscale materials. By using a combination of chemistry and computer simulation we have been able to demonstrate a method by which we can start to see what is going on at the nanoscale.

"If we can understand how peptides self-assemble at the surface of a nanoparticle, we can open up a route towards the design and synthesis of nanoparticles that have complex surfaces. These particles could find applications in the biomedical sciences, for example to deliver drugs to a particular target in the body, or to design sensitive diagnostic tests. In the longer term, these particles could also find applications in new generations of electronic components."

Professor Nigel Brown, BBSRC Director of Science and Technology, said: “Bionanotechnology holds great promise for the future. We may be able to create stronger, lighter and more durable materials, or new medical applications. Basic science and techniques for working at the nanoscale are providing the understanding that will permit future such applications of bionanotechnology.”


Journal reference:

  1. Duchesne et al. Supramolecular Domains in Mixed Peptide Self-Assembled Monolayers on Gold Nanoparticles. ChemBioChem, 2008; NA DOI: 10.1002/cbic.200800326
Adapted from materials provided by Biotechnology and Biological Sciences Research Council.

Thursday, July 17, 2008

Contributing toward finding a cure

By MIKE CAPUTOJuly 17, 2008
While sitting on the couch watching television at his Garden Town home, Dr. Stephen Freedman envisioned a cure for cancer.
His vision was guided by a television feature, which focused on the progress made by Dr. Steven Curley and John Kanzius, who have made strides toward finding a method to kill cancer cells.

After watching that news feature on an April edition of 60 Minutes, Freedman felt compelled to pick up the phone and call Curley. Freedman was confident that his idea could contribute toward achieving nearly every scientist's dream of finding a cure for cancer. But he still couldn't pick up the phone.

"I figured I'd better wait, might as well wait, he will never get back to me," Freedman said. "I mean he is on 60 Minutes, he is probably being barraged with telephone calls."

So he waited. About a month later, Freedman gathered up the courage to make the call to Curley's office at UT MD Anderson Cancer Center in Houston. A receptionist answered, and promised to pass along Freedman's message. Before he even checked for a return call, Freedman had a message waiting for him at his Adelphi University office less than 24 hours after he phoned Curley.

"It was mind-blowing," Freedman said. "I never expected this."

Freedman, a chemistry professor at Adelphi, told Curley that his extensive work with peptides could possibly enhance the renowned researcher's experiment. Curley, a surgeon and medical researcher, teamed up with Kanzius, a cancer patient and a former radio and television technician, to use radiowaves and nanoparticles to kill cancer cells. Using the heat from radiowaves, Curley and Kanzius' method attaches nanoparticles onto antibodies that make their way to the cancer cells to destroy them.

"I have got to tell you in 20 years of research, this is the most exciting thing I have ever encountered," Curley told 60 Minutes.

Freedman, 59, determined that instead of using antibodies, peptides could be more efficient. That is because if nanoparticles attach to the smaller protein-based peptide, they could have an easier time getting to the cancer cells. According to Freedman, Curley took his idea seriously, and plans to run tests sometime in August.

Making an impact on a potentially groundbreaking study to cure cancer is extra special to Freedman, who lost his 75-year-old father to cancer in 1993.

"It was the worst experience of my life, to see my father waste away with cancer," Freedman said. "This whole experiment has a special meaning."

Freedman has lived in Hewlett since 2005, when he started teaching at area colleges, first at St. John's and now at Adelphi. He spent several years teaching chemistry at Florida Atlantic University in Boca Raton. Freedman, who grew up in Brooklyn, earned his doctorate from Utah State University; a Master's of Science from Polytechnic University; and his Bachelor of Science from Brooklyn College.

It's still early in the experimentation process, and there are still many questions to answer. Though he claims not to be religious, Freedman explained that it is important to have faith for such projects to succeed.

"I request that readers say a prayer for a positive result," he said.

However, he does believe luck will factor in.

"We have so many of the greatest minds working on a cure for cancer, yet there is no cure," Freedman said. "It will take a dramatic stroke of luck to come upon the ultimate answer."

Freedman can be contacted by e-mail at freedman@adelphi.edu.

Comments about this story? Mcaputo@liherald.com or (516) 569-4000 ext. 201.
http://www.usu.edu/ust/pdf/2008/july/itn0717085.pdf